0001209191-19-041364.txt : 20190705 0001209191-19-041364.hdr.sgml : 20190705 20190705210018 ACCESSION NUMBER: 0001209191-19-041364 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190705 FILED AS OF DATE: 20190705 DATE AS OF CHANGE: 20190705 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zakrzewski Joseph S CENTRAL INDEX KEY: 0001331852 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21392 FILM NUMBER: 19944139 MAIL ADDRESS: STREET 1: 715 STREET ROAD CITY: NEW HOPE STATE: PA ZIP: 18938 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMARIN CORP PLC\UK CENTRAL INDEX KEY: 0000897448 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: FIRST FLOOR, BLOCK 3, THE OVAL, STREET 2: SHELBOURNE ROAD, BALLSBRIDGE CITY: DUBLIN STATE: L2 ZIP: 00000 BUSINESS PHONE: 353 1 6699 020 MAIL ADDRESS: STREET 1: FIRST FLOOR, BLOCK 3, THE OVAL, STREET 2: SHELBOURNE ROAD, BALLSBRIDGE CITY: DUBLIN STATE: L2 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: AMARIN PHARMACEUTICALS PLC DATE OF NAME CHANGE: 20000201 FORMER COMPANY: FORMER CONFORMED NAME: ETHICAL HOLDINGS PLC DATE OF NAME CHANGE: 19930322 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-07-05 0 0000897448 AMARIN CORP PLC\UK AMRN 0001331852 Zakrzewski Joseph S C/O AMARIN PHARMA, INC. 1430 ROUTE 206 BEDMINSTER NJ 07921 1 0 0 0 Ordinary Shares 2019-07-05 4 M 0 100000 9.00 A 184547 D Ordinary Shares 2019-07-05 4 S 0 100000 23.8158 D 84547 D Stock Option (Right to Buy) 9.00 2019-07-05 4 M 0 100000 0.00 D 2021-10-20 Ordinary Shares 100000 238542 D The option exercises and sale transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Please see the section title "Remarks" below for additional information. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.80 to $23.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The stock option granted to the Reporting Person is fully vested as of the date hereof. This number does not represent the aggregate number of Ordinary Shares of the Issuer this Reporting Person holds or has a right to acquire in the form of stock options and restricted stock units granted to such Reporting Person. /s/ Joseph Kennedy, by power of attorney 2019-07-05